MYELOPROLIFERATIVE DISORDERS
Clinical trials for MYELOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells deployed to hunt down lingering cancer after transplant
Disease control Recruiting nowThis early-stage study is testing a new therapy that uses specially trained immune cells from a donor to try to prevent blood cancers from coming back after a stem cell transplant. The goal is to see if these 'memory-like' natural killer (NK) cells, given with a supporting drug, …
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug timing strategy aims to shield patients from dangerous transplant complication
Disease control Recruiting nowThis study is testing whether changing when a key drug is given can better prevent a serious complication called graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. It will enroll about 29 adults with leukemia or related disorders who are receiving a …
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients to receive new 'T-Cell Redirecting' drug for rare blood cancers
Disease control Recruiting nowThis is the first study in people to test a new drug called JNJ-88549968 for blood cancers with a specific genetic change (CALR mutation). The main goals are to find a safe dose and understand how the body handles the drug. The drug works by guiding a patient's own immune cells t…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New transplant strategy aims to stop devastating immune reaction
Disease control Recruiting nowThis study is testing whether changing the timing of a standard immune-suppressing drug (ATG) can better prevent severe graft-versus-host disease (GVHD) after a stem cell transplant. The trial will enroll 56 adults with acute leukemia, myelodysplastic syndrome, or myeloproliferat…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists test 'Smarter' transplant to fight blood cancers with fewer side effects
Disease control Recruiting nowThis early-stage trial is testing a new approach to stem cell transplants for adults with advanced blood cancers like leukemia. Researchers are modifying the donor cells by adding specific immune cells (regulatory T-cells) alongside the standard transplant. The goal is to help th…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Italian researchers develop advanced cancer testing system
Diagnosis Recruiting nowThis study is testing a new diagnostic platform called IT-TCP that analyzes tumor samples from patients with high-risk cancers. Researchers will collect samples from 300 patients with various cancers including leukemia, pancreatic cancer, and melanoma to see if this detailed anal…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Can diet and exercise ease blood cancer symptoms? new study investigates
Symptom relief Recruiting nowThis study is testing whether a 12-week nutrition and exercise program is practical and helpful for people with myeloproliferative neoplasms (MPNs), a type of chronic blood cancer. Researchers want to see if patients can complete the program and if it improves their fatigue, anxi…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 19, 2026 14:55 UTC
-
AI steps in: can a computer find the right cancer trial for you?
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Italian researchers launch massive blood cancer mapping project
Knowledge-focused Recruiting nowThis study aims to better understand various blood cancers by analyzing patient samples using multiple advanced laboratory techniques. Researchers will examine bone marrow, blood, and tissue samples from 1,040 patients across Italy, both from past collections and new participants…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test hundreds of drugs on patient cancer cells to hunt for new treatments
Knowledge-focused Recruiting nowThis study aims to find new treatments for blood cancers like leukemia. Researchers will test hundreds of approved and experimental drugs on cancer cells taken from 250 patients. The goal is to see which drugs work best on different types of cancer cells and to learn why, which c…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC
-
Scientists hunt for blood test to predict deadly clots in cancer patients
Knowledge-focused Recruiting nowThis study aims to find better ways to predict which patients with certain blood cancers are most likely to develop dangerous blood clots. Researchers will follow 300 patients for two years, testing their blood for specific markers. The goal is to see if these markers can help do…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study aiming to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. who have been diagnosed with an MPN for at least five years, collecting information from …
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC